Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01990313 · ClinicalTrials.gov registry record · NA
Neural Signatures of Parkinson's Disease
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT01990313: Completed NA study, sponsored by Stanford University.
NCT01990313 is a NA study that has completed, run by Stanford University. The registered enrollment target is 15 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01990313, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
The purpose of this study is to provide objective measurements of abnormal movements of the body in correlation with neural activity of the brain and track how these change over time. This may allow for the development of objective evaluation of the neural activity causing abnormal movements, which may lead to the ability of the DBS system to stimulate the brain by sensing the abnormal neural activity that is causing abnormal movements.
Interventions
- DEVICE Activa PC+S
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2013-10 |
| Est. Completion | 2016-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01990313
The ClinicalTrials.gov registry entry for NCT01990313 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Activa PC+S is the first listed.
NCT01990313 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01990313 about?
NCT01990313 is a clinical study titled "Neural Signatures of Parkinson's Disease". The purpose of this study is to provide objective measurements of abnormal movements of the body in correlation with neural activity of the brain and track how these change over time. This may allow for the development of objective evaluation of the neural activity causing abnormal movements, which ...
What is the current status of trial NCT01990313?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2013-10. Estimated completion is 2016-11.
What interventions are being tested in trial NCT01990313?
The interventions under investigation include: Activa PC+S (DEVICE).
Who is sponsoring clinical trial NCT01990313?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.